LT2838539T - Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui - Google Patents

Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui

Info

Publication number
LT2838539T
LT2838539T LTEP13714917.5T LT13714917T LT2838539T LT 2838539 T LT2838539 T LT 2838539T LT 13714917 T LT13714917 T LT 13714917T LT 2838539 T LT2838539 T LT 2838539T
Authority
LT
Lithuania
Prior art keywords
treatment
neurological disorders
estrogenic derivatives
estrogenic
derivatives
Prior art date
Application number
LTEP13714917.5T
Other languages
English (en)
Inventor
Jean-Michel Foidart
Ekaterine Tskitishvili
Original Assignee
Université De Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université De Liege filed Critical Université De Liege
Publication of LT2838539T publication Critical patent/LT2838539T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
LTEP13714917.5T 2012-04-19 2013-04-08 Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui LT2838539T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12164741.6A EP2653163A1 (en) 2012-04-19 2012-04-19 Estrogenic components for use in the treatment of neurological disorders
PCT/EP2013/057279 WO2013156329A1 (en) 2012-04-19 2013-04-08 Estrogenic components for use in the treatment of neurological disorders.

Publications (1)

Publication Number Publication Date
LT2838539T true LT2838539T (lt) 2017-11-27

Family

ID=48050711

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP13714917.5T LT2838539T (lt) 2012-04-19 2013-04-08 Estrogeniniai dariniai, skirti naudoti neurologinių sutrikimų gydymui

Country Status (20)

Country Link
US (1) US9238035B2 (lt)
EP (2) EP2653163A1 (lt)
JP (1) JP6139662B2 (lt)
CN (1) CN104379148B (lt)
AU (1) AU2013248481B2 (lt)
CA (1) CA2869902C (lt)
CY (1) CY1119603T1 (lt)
DK (1) DK2838539T3 (lt)
ES (1) ES2647111T3 (lt)
HR (1) HRP20171627T1 (lt)
HU (1) HUE034902T2 (lt)
LT (1) LT2838539T (lt)
NO (1) NO2838539T3 (lt)
PL (1) PL2838539T3 (lt)
PT (1) PT2838539T (lt)
RS (1) RS56595B1 (lt)
RU (1) RU2627846C2 (lt)
SI (1) SI2838539T1 (lt)
SM (1) SMT201700531T1 (lt)
WO (1) WO2013156329A1 (lt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012164096A1 (en) 2011-06-01 2012-12-06 Estetra S.A. Process for the production of estetrol intermediates
BR112013030833B1 (pt) 2011-06-01 2019-09-03 Estetra S A processo para a preparação de um composto de fórmula (i) e processo para a preparação de estetrol
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
WO2016187558A2 (en) * 2015-05-20 2016-11-24 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Method to improve neurologic outcomes in temperature managed patients
RS57328B1 (sr) 2015-06-18 2018-08-31 Mithra Pharmaceuticals S A Orodisperzibilna dozna jedinica koja sadrži estetrolsku komponentu
NZ737945A (en) * 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
WO2016203044A1 (en) * 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible tablet containing estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
CN107260712A (zh) * 2017-06-22 2017-10-20 中国人民解放军第三军医大学 奥培米芬在制备促进髓鞘形成和再生的药物中的应用
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CR20200486A (es) 2018-04-19 2021-01-27 Estetra Sprl Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
CN113243332B (zh) * 2020-02-07 2023-07-28 上海市东方医院（同济大学附属东方医院） 一种广泛脑区神经元树突发育障碍动物模型的制备与应用
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
HUP2400151A1 (hu) 2024-02-28 2025-09-28 Richter Gedeon Nyrt Ösztetrol-monohidrát kristályosítási eljárás

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
AU2003274943A1 (en) 2002-06-11 2003-12-22 Pantarhei Bioscience B.V. Use of estetrol and analogues for treating or preventing cardiovascular pathologies, in particular atherosclerosis
AU2003274946A1 (en) * 2002-06-11 2003-12-22 Pantarhei Bioscience B.V. Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
AU2006294662A1 (en) * 2005-09-26 2007-04-05 The Regents Of The University Of California Estriol therapy for autoimmune and neurodegenerataive diseases and disorders
EP1971344B1 (en) * 2006-01-09 2010-09-22 Pantarhei Bioscience B.V. A method of treating an acute vascular disorder
US8367647B2 (en) * 2007-06-21 2013-02-05 Pantarhei Bioscience B.V. Treatment of meconium aspiration syndrome with estrogens
AU2008325211B2 (en) * 2007-11-06 2014-11-13 Signal Coordinating Therapy, Inc. Compositions and methods for treating Parkinson's disease and related disorders
CN101884638B (zh) * 2010-07-09 2011-11-09 中山大学 5α-雄甾(烷)-3β,5,6β-三醇在制备神经元保护药物中的应用

Also Published As

Publication number Publication date
RS56595B1 (sr) 2018-02-28
PL2838539T3 (pl) 2018-01-31
WO2013156329A1 (en) 2013-10-24
US20150133419A1 (en) 2015-05-14
AU2013248481A1 (en) 2014-10-30
CY1119603T1 (el) 2018-04-04
PT2838539T (pt) 2017-11-15
EP2838539B1 (en) 2017-08-16
HRP20171627T1 (hr) 2017-12-01
DK2838539T3 (da) 2017-11-27
ES2647111T3 (es) 2017-12-19
RU2014145800A (ru) 2016-06-10
SI2838539T1 (sl) 2017-12-29
CN104379148A (zh) 2015-02-25
RU2627846C2 (ru) 2017-08-14
US9238035B2 (en) 2016-01-19
CA2869902C (en) 2019-07-02
AU2013248481B2 (en) 2017-02-16
EP2838539A1 (en) 2015-02-25
EP2653163A1 (en) 2013-10-23
JP6139662B2 (ja) 2017-05-31
CN104379148B (zh) 2017-08-25
SMT201700531T1 (it) 2018-01-11
NO2838539T3 (lt) 2018-01-13
JP2015514731A (ja) 2015-05-21
CA2869902A1 (en) 2013-10-24
HUE034902T2 (hu) 2018-03-28

Similar Documents

Publication Publication Date Title
SI2838539T1 (sl) Estrogenski derivati za uporabo pri zdravljenju nevroloških motenj
GB2492487B (en) Cannabinoids for use in the treatment of neurodegenerative diseases or disorders
PT3811943T (pt) Composto para uso no tratamento de distúrbios oculares
SG10201912275YA (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3kd related disorders
ZA201503042B (en) Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
IL263661A (en) Combination therapy for the treatment of glioblastoma
IL238027A0 (en) 2-phenyl-5-heterocyclyl-tetrahydro-h2-pyran-3-amine compounds for use in the treatment of diabetes and related disorders
AP2014007804A0 (en) Compositions and methods for the treatment of hepatic diseases and disorders.
PL2726470T3 (pl) Pochodne 1,2,4-tiadiazol-5-ilo piperazyny przydatne w leczeniu chorób neurodegeneracyjnych
HRP20190038T1 (hr) Derivati pantotenata namijenjeni liječenju neuroloških poremećaja
IL235127A (en) Hpn-100 for use in the treatment of nitrogen-related diseases
PL2900230T3 (pl) Związki do leczenia otyłości i sposoby ich zastosowania
ZA201306613B (en) Combinations comprising macitentan for the treatment of glioblastoma multiforme
ZA201504065B (en) Therapeutic agent for keratoconjunctive disorders
ZA201408060B (en) Compositions and methods for the treatment of neurological disorders
PL2861568T3 (pl) Aminy trzeciorzędowe do zastosowania w leczeniu zaburzeń serca
IL237912A0 (en) History of dihydro-6-azaphenylene for the treatment of the central nervous system, oncological diseases and similar disorders
ZA201408061B (en) Compositions and methods for the treatment of neurological disorders
EP2958570A4 (en) THERAPEUTIC COMPOSITION FOR THE TREATMENT OF PERIANAL DISORDERS
AU2012900788A0 (en) Combination treatment for rheumatic disorders
EP2970118A4 (en) COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS